15 news items
UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants
URGN
17 Jun 24
RTGel® reverse-thermal hydrogel, a proprietary sustained-release, hydrogel-based platform technology that has the potential to improve
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
URGN
17 Jun 24
RTGel® reverse-thermal hydrogel, a proprietary sustained-release, hydrogel-based platform technology that has the potential
Hasbro, Tutor Perini, Arm Holdings And Other Big Stocks Moving Higher On Friday
ADBE
ARM
ECX
14 Jun 24
) climbed 9.9% to $4.32. VinFast Auto anticipates sustained growth for next five years and approaching break-even point.
Tutor Perini
UroGen Announces Unprecedented 82.3% Duration of Response at 12 Months in the ENVISION Trial Investigating UGN-102 as Potentially the First FDA-Approved Non-Surgical Treatment for LG-IR-NMIBC
URGN
13 Jun 24
of LG-IR-NMIBC. Utilizing UroGen's proprietary RTGel® technology, a sustained release, hydrogel-based
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
URGN
7 Jun 24
RTGel® reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology
1exl27g4qqy0gc3c9u 5qetpr1lrnw08kog333mu1i4s73rp5sf5hho
URGN
5 Jun 24
. UroGen has developed RTGel reverse-thermal hydrogel, a proprietary sustained-release, hydrogel-based platform technology that has the potential
ni4 llcppfnrwa135n4
URGN
22 May 24
cancers because patients deserve better options. UroGen has developed RTGel reverse-thermal hydrogel, a proprietary sustained-release, hydrogel-based
w3gbvin9tp7cxxjnq4c2lir5ejxz17wpl5yf71g2g8viad
URGN
6 May 24
xa0w8i8wmyv7hec2uz7fjp h3m8clpas7yvy
URGN
5 May 24
hydrogel, a proprietary sustained-release, hydrogel-based platform technology that has the potential to improve the therapeutic profiles of existing
nuff9wh
URGN
4 May 24
® technology, a sustained release, hydrogel-based formulation, UGN-102 is designed to enable longer exposure of bladder tissue to mitomycin
ysdvl3lvq sdoti2vo4dz0whwz
URGN
4 May 24
sustained-release, hydrogel-based platform technology that has the potential to improve the therapeutic profiles of existing drugs. UroGen's sustained
nipey3uzi74tjzo4ar8 3m8pz4rtp14g9telx39t
URGN
3 May 24
, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGen's
jil8snpsfurhhmqtn6 l74etqvmm4oqxbw4roo4iv56icpdg2xc1lcg27fj
URGN
17 Apr 24
RTGel® technology, a sustained release, hydrogel-based formulation, UGN-102 is designed to enable longer exposure
ata3l8fa7pta0nf
URGN
15 Apr 24
formulation uses UroGen's RTGel® platform technology, a proprietary sustained-release, reverse-thermal hydrogel that can improve
7jizm1c2
URGN
15 Apr 24
RTGel® platform technology, a proprietary sustained-release, reverse-thermal hydrogel that can improve
- Prev
- 1
- Next